Cargando…
The Exceptional Oncogenicity of HTLV-1
Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus identified in 1979 by the Gallo group. HTLV-1 causes fatal T-cell leukemia (adult T cell leukemia) and a progressive myelopahy (HTLV-1-associated myelopathy/ tropical spastic paraparesis, HAM/TSP) and other disorders. Si...
Autores principales: | Tagaya, Yutaka, Gallo, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539117/ https://www.ncbi.nlm.nih.gov/pubmed/28824561 http://dx.doi.org/10.3389/fmicb.2017.01425 |
Ejemplares similares
-
Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective
por: Gallo, Robert C., et al.
Publicado: (2022) -
Time to Go Back to the Original Name
por: Gallo, Robert C., et al.
Publicado: (2017) -
How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?
por: Gazon, Hélène, et al.
Publicado: (2018) -
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators
por: Forlani, Greta, et al.
Publicado: (2013) -
Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)